Selected research
Industry Research
Propranolol Industry Research Report 2026
Market perspective
The global Propranolol market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Propranolol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Propranolol is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Propranolol is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Propranolol include Yabang Pharma, Teva, Sanofi, Novartis, Mylan, AstraZeneca, Zydus Pharma, Zentiva and Towa Yakuhin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Propranolol market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Propranolol Market by Company
Yabang Pharma
Teva
Sanofi
Novartis
Mylan
AstraZeneca
Zydus Pharma
Zentiva
Towa Yakuhin
Sawai Seiyaku
Nichi-Iko Pharmaceutical
Iqfarma
Intas Pharma
IFET
Atnas Pharma
Apotex
ABZ-Pharma
Propranolol Segment by Type
Oral
Injection
Propranolol Segment by Application
Arrhythmia
Hypertension
Others
Propranolol Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propranolol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Propranolol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propranolol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Propranolol manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Propranolol by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Propranolol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Injection
Applications
- Arrhythmia
- Hypertension
- Others
Companies covered
- Yabang Pharma
- Teva
- Sanofi
- Novartis
- Mylan
- AstraZeneca
- Zydus Pharma
- Zentiva
- Towa Yakuhin
- Sawai Seiyaku
- Nichi-Iko Pharmaceutical
- Iqfarma
- Intas Pharma
- IFET
- Atnas Pharma
- Apotex
- ABZ-Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Propranolol Market Size (2021-2032)
- 2.2.2 Global Propranolol Sales (2021-2032)
- 2.2.3 Global Propranolol Market Average Price (2021-2032)
- 2.3 Propranolol by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral
- 2.3.3 Injection
- 2.4 Propranolol by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Arrhythmia
- 2.4.3 Hypertension
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Propranolol Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Propranolol Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Propranolol Revenue of Manufacturers (2021-2026)
- 3.4 Global Propranolol Average Price by Manufacturers (2021-2026)
- 3.5 Global Propranolol Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Propranolol, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Propranolol, Product Type & Application
- 3.8 Global Manufacturers of Propranolol, Established Date
- 3.9 Global Propranolol Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yabang Pharma
- 4.1.1 Yabang Pharma Company Information
- 4.1.2 Yabang Pharma Business Overview
- 4.1.3 Yabang Pharma Propranolol Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yabang Pharma Propranolol Product Portfolio
- 4.1.5 Yabang Pharma Recent Developments
- 4.2 Teva
- 4.2.1 Teva Company Information
- 4.2.2 Teva Business Overview
- 4.2.3 Teva Propranolol Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Teva Propranolol Product Portfolio
- 4.2.5 Teva Recent Developments
- 4.3 Sanofi
- 4.3.1 Sanofi Company Information
- 4.3.2 Sanofi Business Overview
- 4.3.3 Sanofi Propranolol Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi Propranolol Product Portfolio
- 4.3.5 Sanofi Recent Developments
- 4.4 Novartis
- 4.4.1 Novartis Company Information
- 4.4.2 Novartis Business Overview
- 4.4.3 Novartis Propranolol Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novartis Propranolol Product Portfolio
- 4.4.5 Novartis Recent Developments
- 4.5 Mylan
- 4.5.1 Mylan Company Information
- 4.5.2 Mylan Business Overview
- 4.5.3 Mylan Propranolol Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Mylan Propranolol Product Portfolio
- 4.5.5 Mylan Recent Developments
- 4.6 AstraZeneca
- 4.6.1 AstraZeneca Company Information
- 4.6.2 AstraZeneca Business Overview
- 4.6.3 AstraZeneca Propranolol Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 AstraZeneca Propranolol Product Portfolio
- 4.6.5 AstraZeneca Recent Developments
- 4.7 Zydus Pharma
- 4.7.1 Zydus Pharma Company Information
- 4.7.2 Zydus Pharma Business Overview
- 4.7.3 Zydus Pharma Propranolol Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Zydus Pharma Propranolol Product Portfolio
- 4.7.5 Zydus Pharma Recent Developments
- 4.8 Zentiva
- 4.8.1 Zentiva Company Information
- 4.8.2 Zentiva Business Overview
- 4.8.3 Zentiva Propranolol Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Zentiva Propranolol Product Portfolio
- 4.8.5 Zentiva Recent Developments
- 4.9 Towa Yakuhin
- 4.9.1 Towa Yakuhin Company Information
- 4.9.2 Towa Yakuhin Business Overview
- 4.9.3 Towa Yakuhin Propranolol Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Towa Yakuhin Propranolol Product Portfolio
- 4.9.5 Towa Yakuhin Recent Developments
- 4.10 Sawai Seiyaku
- 4.10.1 Sawai Seiyaku Company Information
- 4.10.2 Sawai Seiyaku Business Overview
- 4.10.3 Sawai Seiyaku Propranolol Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sawai Seiyaku Propranolol Product Portfolio
- 4.10.5 Sawai Seiyaku Recent Developments
- 4.11 Nichi-Iko Pharmaceutical
- 4.11.1 Nichi-Iko Pharmaceutical Company Information
- 4.11.2 Nichi-Iko Pharmaceutical Business Overview
- 4.11.3 Nichi-Iko Pharmaceutical Propranolol Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Nichi-Iko Pharmaceutical Propranolol Product Portfolio
- 4.11.5 Nichi-Iko Pharmaceutical Recent Developments
- 4.12 Iqfarma
- 4.12.1 Iqfarma Company Information
- 4.12.2 Iqfarma Business Overview
- 4.12.3 Iqfarma Propranolol Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Iqfarma Propranolol Product Portfolio
- 4.12.5 Iqfarma Recent Developments
- 4.13 Intas Pharma
- 4.13.1 Intas Pharma Company Information
- 4.13.2 Intas Pharma Business Overview
- 4.13.3 Intas Pharma Propranolol Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Intas Pharma Propranolol Product Portfolio
- 4.13.5 Intas Pharma Recent Developments
- 4.14 IFET
- 4.14.1 IFET Company Information
- 4.14.2 IFET Business Overview
- 4.14.3 IFET Propranolol Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 IFET Propranolol Product Portfolio
- 4.14.5 IFET Recent Developments
- 4.15 Atnas Pharma
- 4.15.1 Atnas Pharma Company Information
- 4.15.2 Atnas Pharma Business Overview
- 4.15.3 Atnas Pharma Propranolol Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Atnas Pharma Propranolol Product Portfolio
- 4.15.5 Atnas Pharma Recent Developments
- 4.16 Apotex
- 4.16.1 Apotex Company Information
- 4.16.2 Apotex Business Overview
- 4.16.3 Apotex Propranolol Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Apotex Propranolol Product Portfolio
- 4.16.5 Apotex Recent Developments
- 4.17 ABZ-Pharma
- 4.17.1 ABZ-Pharma Company Information
- 4.17.2 ABZ-Pharma Business Overview
- 4.17.3 ABZ-Pharma Propranolol Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 ABZ-Pharma Propranolol Product Portfolio
- 4.17.5 ABZ-Pharma Recent Developments
5 Global Propranolol Market Scenario by Region
- 5.1 Global Propranolol Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Propranolol Sales by Region: 2021-2032
- 5.2.1 Global Propranolol Sales by Region: 2021-2026
- 5.2.2 Global Propranolol Sales by Region: 2027-2032
- 5.3 Global Propranolol Revenue by Region: 2021-2032
- 5.3.1 Global Propranolol Revenue by Region: 2021-2026
- 5.3.2 Global Propranolol Revenue by Region: 2027-2032
- 5.4 North America Propranolol Market Facts & Figures by Country
- 5.4.1 North America Propranolol Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Propranolol Sales by Country (2021-2032)
- 5.4.3 North America Propranolol Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Propranolol Market Facts & Figures by Country
- 5.5.1 Europe Propranolol Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Propranolol Sales by Country (2021-2032)
- 5.5.3 Europe Propranolol Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Propranolol Market Facts & Figures by Country
- 5.6.1 Asia Pacific Propranolol Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Propranolol Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Propranolol Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Propranolol Market Facts & Figures by Country
- 5.7.1 South America Propranolol Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Propranolol Sales by Country (2021-2032)
- 5.7.3 South America Propranolol Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Propranolol Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Propranolol Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Propranolol Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Propranolol Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Propranolol Sales by Type (2021-2032)
- 6.1.1 Global Propranolol Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Propranolol Sales Market Share by Type (2021-2032)
- 6.2 Global Propranolol Revenue by Type (2021-2032)
- 6.2.1 Global Propranolol Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Propranolol Revenue Market Share by Type (2021-2032)
- 6.3 Global Propranolol Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Propranolol Sales by Application (2021-2032)
- 7.1.1 Global Propranolol Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Propranolol Sales Market Share by Application (2021-2032)
- 7.2 Global Propranolol Revenue by Application (2021-2032)
- 7.2.1 Global Propranolol Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Propranolol Revenue Market Share by Application (2021-2032)
- 7.3 Global Propranolol Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Propranolol Value Chain Analysis
- 8.1.1 Propranolol Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Propranolol Production Mode & Process
- 8.2 Propranolol Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Propranolol Distributors
- 8.2.3 Propranolol Customers
9 Global Propranolol Analyzing Market Dynamics
- 9.1 Propranolol Industry Trends
- 9.2 Propranolol Industry Drivers
- 9.3 Propranolol Industry Opportunities and Challenges
- 9.4 Propranolol Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst